These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12112848)

  • 61. Glycoform characterization of erythropoietin combining glycan and intact protein analysis by capillary electrophoresis - electrospray - time-of-flight mass spectrometry.
    Balaguer E; Demelbauer U; Pelzing M; Sanz-Nebot V; Barbosa J; Neusüss C
    Electrophoresis; 2006 Jul; 27(13):2638-50. PubMed ID: 16817164
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proteomic analysis of human bronchoalveolar lavage fluid: expression profiling of surfactant-associated protein A isomers derived from human pulmonary alveolar proteinosis using immunoaffinity detection.
    He C
    Proteomics; 2003 Jan; 3(1):87-94. PubMed ID: 12548638
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control.
    Reichel C; Benetka W; Lorenc B; Thevis M
    Drug Test Anal; 2016 Nov; 8(11-12):1131-1137. PubMed ID: 27552163
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Isoforms analysis of recombinant human erythropoietin by polarity-reversed capillary isoelectric focusing.
    Ren TJ; Zhang XX; Li X; Chen HX
    Electrophoresis; 2020 Dec; 41(23):2055-2061. PubMed ID: 32841408
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determination of somatropin charged variants by capillary zone electrophoresis - optimisation, verification and implementation of the European pharmacopoeia method.
    Storms SM; Feltus A; Barker AR; Joly MA; Girard M
    Pharmeur Sci Notes; 2009 Mar; 2009(1):25-36. PubMed ID: 19275870
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New urinary EPO drug testing method using two-dimensional gel electrophoresis.
    Khan A; Grinyer J; Truong ST; Breen EJ; Packer NH
    Clin Chim Acta; 2005 Aug; 358(1-2):119-30. PubMed ID: 15907825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The molecular structure of human erythropoietin.
    Romanowski RR; Sytkowski AJ
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):885-94. PubMed ID: 7852212
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterisation of human serum albumin heterogeneity by capillary zone electrophoresis and electrospray ionization mass spectrometry.
    Girard M; Bietlot HP; Cyr TD
    J Chromatogr A; 1997 Jun; 772(1-2):235-42. PubMed ID: 9226928
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation.
    Yang M; Butler M
    Biotechnol Bioeng; 2000 May; 68(4):370-80. PubMed ID: 10745205
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quality control and stability studies with the monoclonal antibody, trastuzumab: application of 1D- vs. 2D-gel electrophoresis.
    Nebija D; Noe CR; Urban E; Lachmann B
    Int J Mol Sci; 2014 Apr; 15(4):6399-411. PubMed ID: 24739811
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differences in sialic acid O-acetylation between human urinary and recombinant erythropoietins: a possible mass spectrometric marker for doping control.
    Reichel C
    Drug Test Anal; 2013; 5(11-12):877-89. PubMed ID: 24353190
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biological and physicochemical characterization of recombinant human erythropoietins fractionated by Mono Q column chromatography and their modification with sialyltransferase.
    Morimoto K; Tsuda E; Said AA; Uchida E; Hatakeyama S; Ueda M; Hayakawa T
    Glycoconj J; 1996 Dec; 13(6):1013-20. PubMed ID: 8981093
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin.
    Reichel C; Thevis M
    Bioanalysis; 2013 Mar; 5(5):587-602. PubMed ID: 23425274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin.
    Liu L; Li H; Hamilton SR; Gomathinayagam S; Rayfield WJ; van Maanen M; Yin KC; Hong L; Prueksaritanont T
    J Pharm Sci; 2012 Dec; 101(12):4414-8. PubMed ID: 22987365
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 2D-ToGo workflow: increasing feasibility and reproducibility of 2-dimensional gel electrophoresis.
    Posch A; Franz T; Hartwig S; Knebel B; Al-Hasani H; Passlack W; Kunz N; Hinze Y; Li X; Kotzka J; Lehr S
    Arch Physiol Biochem; 2013 Jul; 119(3):108-13. PubMed ID: 23679042
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of methods for determination of glycan composition of erythropoietin.
    Cowper B; Burns C; Bristow AF; Letallec D; Costanzo A
    Pharmeur Bio Sci Notes; 2019; 2019():34-53. PubMed ID: 31767053
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Physicochemical and biological comparison of recombinant human erythropoietin with human urinary erythropoietin.
    Imai N; Kawamura A; Higuchi M; Oh-eda M; Orita T; Kawaguchi T; Ochi N
    J Biochem; 1990 Mar; 107(3):352-9. PubMed ID: 2341370
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties.
    Sytkowski AJ; Lunn ED; Risinger MA; Davis KL
    J Biol Chem; 1999 Aug; 274(35):24773-8. PubMed ID: 10455149
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A probable conformational difference between recombinant and urinary erythropoietins.
    Kung CK; Goldwasser E
    Proteins; 1997 May; 28(1):94-8. PubMed ID: 9144794
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clarification on the detection of epoetin delta and epoetin omega using isoelectric focusing.
    Belalcazar V; Ventura R; Segura J; Pascual JA
    Am J Hematol; 2008 Sep; 83(9):754; author reply 754-5. PubMed ID: 18543344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.